Phong Phu Pharmaceutical JSC (HNX:PPP)

Vietnam · Delayed Price · Currency is VND

20,100

+300 (1.52%)

At close: Oct 29, 2026

Market Cap	176.88B +6.3%
Revenue (ttm)	167.82B +24.3%
Net Income	35.74B +114.9%
EPS	4,141.97 +133.1%
Shares Out	8.80M
PE Ratio	4.85
Forward PE	n/a
Dividend	1,500.00 (7.46%)
Ex-Dividend Date	Mar 19, 2026

Volume	1,611
Open	20,100
Previous Close	19,800
Day's Range	20,100 - 20,100
52-Week Range	17,700 - 21,700
Beta	-0.14
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 4, 2026

About HNX:PPP

Phong Phu Pharmaceutical Joint Stock Company engages in the production, sale, and distribution of medicines primarily in Vietnam. The company’s medicines are derived from medicinal herbs, pharmaceutical chemicals, and health supplements. It engages in wholesale of other household products; tea production; manufacture of dairy products, bakery products, macaroni, noodles and similar farinaceous products, non-alcoholic beverages, mineral waters, medical and dental, orthopedic and rehabilitation instruments supplies, cosmetics, soap and detergents... [Read more]

Industry Pharmaceutical Preparations

Founded 2000

Employees 136

Stock Exchange Hanoi Stock Exchange

Ticker Symbol PPP

Full Company Profile

Financial Performance

In 2025, HNX:PPP's revenue was 139.74 billion, an increase of 1.59% compared to the previous year's 137.55 billion. Earnings were 16.57 billion, an increase of 6.58%.

Financial Statements